Sell 1/30/2025Downgrade
Simcere Pharmaceutical Group Limited (SMHGF) was downgraded to E from D on 01/30/2025.

Sell 11/4/2024Downgrade
Simcere Pharmaceutical Group Limited (SMHGF) was downgraded to D from D+ on 11/4/2024 due to a significant decline in the valuation index, efficiency index and growth index. Net income declined 0.86% from $31.8M to $31.53M, total revenue declined 0.86% from $216.84M to $214.98M, and operating cash flow declined 0.86% from $60.08M to $59.56M.

Sell 7/1/2024Downgrade
Simcere Pharmaceutical Group Limited (SMHGF) was downgraded to D+ from C- on 7/1/2024 due to a decline in the volatility index.

Hold 5/3/2024Upgraded
Simcere Pharmaceutical Group Limited (SMHGF) was upgraded to C- from D+ on 5/3/2024 due to an increase in the total return index and volatility index.

Sell 4/17/2024None
Simcere Pharmaceutical Group Limited (SMHGF) was downgraded to D+ from U on 04/17/2024.